The aim of the present study was to test the hypothesis that immobilisation of bone morphogenic proteins on the surface of titanium implants through nano-anchored oligonucleotides can enhance peri-implant bone formation. Non-coding 60-mer DNA oligonucleotides (ODN) were anchored to the surface of custom made sandblasted acid etched (SAE) titanium screw implants through anodic polarisation, gamma-sterilised with a standard dose of 25 kGy, and were hybridised with complementary 30-mer strands of DNA oligonucleotides conjugated to rhBMP2. Blank SAE implants, SAE implants with nano-anchored ODN and SAE implants with nano-anchored ODN and non-conjugated rhBMP2 served as controls. The implants were inserted into the tibiae of 36 Sprague Dawley rats. Perforations at the head and the tip of the implants allowed for bone ingrowth. Bone ingrowth into perforations and bone implant contact (BIC) as well as bone density (BD) at a distance of 200 µm from the implant surface were assessed after 1 , 4 and 13 weeks. Implants with nano-anchored ODN strands hybridised with conjugated rhBMP2 exhibited enhanced bone ingrowth into the perforations and increased BIC after 1 week as well as increased BIC after 4 weeks compared to controls. No difference was seen after 13 weeks. Bone density around the outer implant surface did not differ significantly at any of the intervals. It is concluded that rhBMP2 immobilised on the surface of titanium implants through nano-anchored oligonucleotide strands can enhance bone implant contact. The conditions of sterilisation tested allowed for handling under clinically relevant conditions.
Introduction
Osseointegration of titanium implants requires new bone tissue to be formed on the implant surface by the adjacent peri-implant bone. Under healthy conditions, this process is reliably efficient and leads to long term integration of the implant in the surrounding bone. Sites of implantation with compromised biology, however, may be unable to accomplish the required level of osteogenic activity leading to inferior quality of bone anchorage (Pan et al., 2000; McCracken et al., 2000; Keller et al., 2004) . In order to enhance the process of peri-implant bone formation and implant anchorage, numerous approaches have been used to bind signalling molecules to the implant surfaces that are considered to enhance osteogenesis. Among the available growth factors, bone morphogenic proteins (BMPs) and vascular endothelial growth factor (VEGF) have been most frequently used to achieve this goal (Thorey et al., 2011; Ramazanoglu et al., 2013; Leknes et al., 2013; Mueller et al., 2011) . However, massive overdosage in the use of recombinant BMP2 due to the lack of established low release systems has been discussed to lead to a number of complication in clinical applications such as excessive swelling, heterotopic ossification, seroma formation, pleural effusions and spinal complications (Beidas et al., 2013; Merrick et al., 2013; Shweikeh et al., 2014; Muchow et al., 2010) .
The challenge of all approaches, using biologically active molecules in conjunction with titanium implants, is to achieve both reversible binding of growth factors to the metal surface and controlled delivery of active signals. Beyond simple adsorption, organic molecules such as phosphonate anchors (Adden et al., 2006a; 2006b) , collagen and chondroitin sulphate (Schliephake et al., 2005 Stadlinger et al., 2008) , heparin or chitosan in conjunction with silane or dopamine (Zheng et al., 2013; Kim et al., 2011 Lee et al., 2012) as well as polylactic acid (Choi et al., 2014; Thorey et al., 2011) have been employed to achieve anchorage of growth factors to the surfaces of titanium implants.
Regardless of which strategy has been used, growth factors bound to the surface of titanium implants during the fabrication process may become denaturalised and inactivated during sterilisation as the final step of production. Binding of growth factors to implant surfaces after sterilisation and immediately prior to insertion through adsorption using dip coating has been associated with a burst release that has shown negative effects for implant healing (Leknes et al., 2008; . Thus, a system for binding and controlled delivery of biologically active molecules would be desirable that can be applied "table side" immediately prior to www.ecmjournal.org H Schliephake et al. Immobilisation of bone morphogenic protein 2 on titanium implants insertion. Following the idea that the structure of DNA strands is resistant to γ-sterilisation under appropriate conditions, oligonucleotide DNA (ODN) strands have been recently explored for binding of biologically active molecules to titanium surfaces through hybridisation with complementary ODN strands conjugated to RGD peptides ). Moreover, in vitro studies on binding and release of bone morphogenic protein 2 (rhBMP2) and vascular endothelial growth factor (VEGF165) conjugated to ODN strands have shown that growth factors are efficiently bound to the titanium surface through hybridising with complementary nano-anchored oligonucleotides and that biologically active molecules are released from these surfaces in a retarded fashion (Schliephake et al., 2012a (Schliephake et al., , 2012b . In order to utilise this principle for in vivo applications, conditions have to be identified that safeguard the integrity of the ODN anchor strands (AS) partially incorporated into the anodic oxide layers on the titanium surfaces during gamma sterilisation. In particular, the concentrations of reactive species produced due to the interaction of gamma quanta with water and oxygen as components of the sterilisation environment of the ODN have to be drastically reduced to prevent a degradation of the ASs.
The aim of the present study was therefore i) to identify conditions for γ-sterilisation of oligonucleotides nano-anchored to the surface of titanium implants that do not substantially reduce their ability to hybridise with complementary strands conjugated to bone morphogenic protein 2 (BMP2), and ii) to test the hypothesis that BMP2 bound to the surface of titanium implants through nanoanchored ODN strands under these conditions enhances peri-implant bone formation in vivo in a model.
Materials and Methods

Sample disc and implant fabrication
Custom made sample discs (Ø 14.7 mm × 2 mm) and selfcutting screw implants of 2.00 mm diameter and 5.00 mm length were fabricated from commercially pure titanium (KLS Martin, Tuttlingen, Germany). Two perforations of 0.8 mm diameter through the implant body at the tip and the head were created to allow for bone ingrowth (Fig.  1A) . The surfaces of the implants and sample discs were prepared by sandblasting and subsequent acid-etching in 5.1 M hydrochloric acid and 4.6 M sulphuric acid solution for 300 s at 108 °C (Schliephake et al., 2012a) . Sixty-mer anchor strands and thirty-two-mer sacrificial strand 2 were synthesised by Thermo Fisher Scientific GmbH (Ulm, Germany). Thirty-one-mer oligonucleotides (GS-ODN) complementary to the anchor strands were synthesised by Thermo Fisher Scientific GmbH (Ulm, Germany).
Radio labelling of the GS-ODN was done over 3'-elongation with 32 P-dNTPs by Hartmann Analytics GmbH (Braunschweig, Germany). For immobilisation of the ODN anchor strands (AS), an electrochemical setup was used that has already been described by . In short, for both the sample discs and the implants, a conventional three-electrode setup was used with a spiral gold wire acting as auxiliary electrode and a saturated Ag/AgCl reference electrode connected to the cell via a salt bridge made from a tube filled with agarose gel (2 % w/v in 2 mol L -1 acetate buffer, pH 4.0). Sample discs were treated mounted to the bottom (Ti) of a conical cell made from polyetherimide. Implants were screwed on to a custom made mount. Initial adsorption of the anchor strands on the sample discs was performed in 300 µL each and on the implants in 100 µL of 0.5 mol L -1 acetate buffer at pH 4.0 with additional 5 mol L -1 ethanol for 15 min. The electrolyte contained 800 nmol L -1 AS. After adsorption, 6 mL buffer (analogous to the adsorption electrolyte) were added to the cell and the anodic polarisation was started within 20 s. The implants were placed in a conical teflon cell with the similar setup to that of the sample discs. The potentiostat/galvanostat (Voltalab 4.0, Radiometer Analytical, Lyon, France) was operated in galvanostatic mode with 11 mA cm -2 to ensure a polarisation time of approx. 3 s to reach a potential of 7.5 V Ag/AgCl . After polarisation, all samples were subsequently rinsed two times with 9 mL buffer inside the cell, followed by dipping the samples in sterile de-ionised water (SDI) H 2 O to remove the buffer. Subsequently, the samples were dried for 2 h at room temperature (RT) in the dark. 
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Sterilisation
For the in vitro experiments, sample discs were sterilised using γ-radiation sterilisation ( 60 Co) with a minimum dose of 25 kGy (Synergy Health Radeberg GmbH, Radeberg, Germany). After ideal conditions for sterilisation have been identified, through evaluation of the sample discs for the ability of their AS to hybridise with complementary ODN strands (CS), sterilisation of the implants for in vivo experiments was performed with the same type of irradiation and dosage but under the conditions identified as ideal in the in vitro experiments.
In vitro experiments
Preservation of AS integrity during sterilisation Immobilisation of AS was done according to the process described under electrochemical immobilisation and not incorporated AS were removed by storage of the samples for 24 h in 15 mL of PBS (per sample). The strategy for preservation of AS hybridisation ability during sterilisation aimed at two aspects of possible damage.
First, strategies were developed to minimise damage to AS by reactive oxygen species. Second, the AS were protected by using sacrificial ODN strands that were supposed to cover the AS, to reduce their contact to the underlying substrate surface, and become preferred subject to damaging effects of residual oxygen radicals.
The first approach was accomplished by employing different methods of drying and creating anti-oxidative variations in atmosphere during sterilisation and packing. Two strategies were used for drying: (i) Air drying: the samples were dried 2 h at room temperature in the dark, (ii) Phosphorus pentoxide (PPO) drying: sample discs were dried for 2 h at room temperature in the dark and then dried for 48 h over PPO under vacuum (3 kPa) .
Three variations in combination with an anti-oxidative atmosphere during sterilisation and packing were used: (i) ethanol atmosphere: After drying of the sample discs, they were packed in a bottle (1250 mL) with 3 mL Ethanol, (ii) Wet Ar-Atm: The sample discs were transferred and sealed in alu peel bags (Früh Verpackungstechnik, Fehraltorf, Switzerland) in water containing argon-atmosphere, (iii) Ar-EtOH-Atm: After drying the sample discs were packed in 10 mL bottles and transferred in 1250 mL bottles with 1 mL ethanol (water free > 30 ppm) to realise an argonethanol-atmosphere. The transfer and packing took place in a glove box (MB 150B-G-II, MBraun, Garching, Germany).
For the second approach using sacrificial strands, two different designs of sacrificial strands (SCS) were investigated. SCS1 is identical to AS but not incorporated into the anodic oxide surface and SCS2 (32mer) has a sequence designed for minimal interaction with both, AS and CS (Table 1 ). All ODN strands were synthesised by Thermo Fisher Scientific GmbH (Ulm, Germany).
The effect of SCSs on the hybridisation behaviour of immobilised AS was investigated for three ranges of surface concentrations. For SCS1, the concentration range (a) between 4.5-7.5 pmol/cm 2 was realised by skipping the removal step (storage of samples for 24 h in PBS; see above) the range (b) between 32.5-35.5 pmol/cm 2 was realised by adding 50 µL of 800 nM SCS1 solution on the sample. For SCS2, a concentration of 56 pmol/cm 2 was realised by adding 50 µL of 1.6 µM SCS2 solution on the sample after removing the not incorporated AS.
For analysis of hybridisation ability samples were placed in a 12 well plate and 100 µL of the hybridisation solution was added containing 400 nM GS-ODN in phosphate buffered saline (PBS, pH 7.4). Hybridisation was performed with 32P-labeled CS (0.05-0.2 %) to quantify the surface density. The hybridisation took place for 1 h in the dark. Afterwards each sample was washed 3 times with 3 mL 1 × PBS to remove strands not hybridised and dipped in water to remove salt residues. Radioactivity of all samples was measured using a passivated implanted planar silicon detector (PIPS-detector) based spectrometry (Canberra/Ortec, Meriden, USA / Oak Ridge, USA), from which the amount of labelled strand, and subsequently the GS-ODN surface density was calculated.
The reference, without sterilisation, was prepared according to the investigated conditions and stored at room temperature during the sterilisation process. Reference experiments, using non-sense GS-ODN, gave surface densities below 0.3 pmol/cm 2 (results not shown) for all experimental conditions. In total, eight sets of combinations of environments and SCSs were evaluated ( Table 2) . Because of a negative influence of amounts of SCS1 (b) on the hybridisation ability was anticipated (Sets 4 and 8), a removal step (storage of 2 h in 5 mL 1 × PBS) was performed with Table 1 . Name, sequence and length of the used Oligodesoxyribonucleotides (ODN).
Name Sequence
Length in mer AS: (anchor strand) two hybridisation areas underlined (SCS1) also used as sacrificial strand 
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these sets after sterilisation prior to the hybridisation. Six samples were analysed per set.
Evaluation of the efficacy of the sterilisation process
For the investigation of sterility, sample discs were prepared as described above for immobilisation of anchor strands and dried two days over phosphorous pentoxide. Pseudomonas putida (ATCC 17390, Institute for Microbiology, University of Hohenheim, Germany) were cultivated for 24 h in nutrient broth (0.3 % beef extract, 0.5 % yeast extract, 0.5 % Peptone and 0.5 % NaCl, pH 7) before added to the samples. 50 µL of the cultivated Pseudomonas putida (corresponding to 25 × 10 6 CFU) were added to the samples and dried. Then the samples were packed in alu peel bags under water containing argon-atmosphere (glove bag) and sterilised with 25 kGy. Following, each sample was placed in 3 mL nutrient medium and incubated for 12 h on a shaker (150 rpm). The samples were rinsed and the solution was plated. The optical density of the solution was measured, at 600 nm, to determine the colony forming unites (CFU) of the plated solution. Pure nutrient broth was used as a control.
Conjugation of complementary oligonucleotides to rhBMP2 (BMP-ODN) and hybridisation of BMP-ODN conjugates to nano-anchored AS
For both in vitro release measurements as well as in vivo evaluation, conjugation of rhBMP2 (E. coli) (Reliatech, Braunschweig, Germany, product code: http://www.reliatech.de/fileadmin/ds/ch/200-002.pdf) with complementary oligonucleotides (CS) was done, by using disuccinimidyl suberate (DSS) as linker molecule. In a first step the aminomodified GS-ODN was activated with DSS in 1 mM acetate buffer pH 4.0. The excess DSS was separated using an illustra NAP-10 column (GE Healthcare, Freiburg, Germany). The DSS-activated CS-ODN was mixed with rhBMP2 in phosphate buffered saline (PBS) containing 2 M sodium chloride pH 7.4 and incubated at room temperature for at least 18 h.
According to the assessment of preservation of AS integrity during sterilisation, surfaces sterilised under the conditions of set 7 were used for the in vitro evaluation of binding and release. Loading of titanium surfaces was performed as described previously (Schliephake et al., 2012a) . For each disc, 100 µL of BMP-ODN solution was prepared by mixing 10 µL of PBS, 80 µL of pure water and 10 µL of conjugated growth factor solution containing 715 ng of rhBMP2. The volumes of 100 µL were pipetted onto the discs and left for hybridisation in a dark chamber at room temperature for 1 h. Care was taken to accommodate the complete volume on the disc surface. Subsequently, the specimens were washed three times in PBS. The amount of BMP that was washed away was measured using a custom made commercially produced sandwich ELISA (Dr. Mark Hennies, Euskirchen, Germany). Four discs were evaluated and measurements were performed in duplicate.
In vitro release and bioactivity of growth factor conjugates
The release of conjugated and non-conjugated rhBMP2 was assessed as described previously (Schliephake et al., 2012a) . Discs were placed in cell culture medium (DMEM, 1 g Glc/L, Biochrom, Berlin, Germany) in BSA coated 24-well plates. The medium was collected and replaced after, 3 h, 24 h, 3 d, 7 d, 14 d and 21 d. The amount of released BMP2 was assessed using the custom made commercially produced sandwich ELISA mentioned above. The minimum detectable amount was 100 pg/mL BMP2. Four discs from each group were evaluated at each interval for the release experiments. All measurements were performed in duplicate.
In order to test whether the conjugated rhBMP2 differed in its osteogenic activity from the non-conjugated rhBMP2, biological activity was evaluated by induction of Alkaline Phosphatase (AP) in C2C12 cells (www. dsmz.de): 7.5 × 10 5 cells were seeded and grown in 1 mL Medium (DMEM, 1.0 g Glc, 10 % FCS (Biochrom, Berlin, Germany) for 72 h after which the control medium, medium containing released non-conjugated BMP2/ conjugated BMP2, respectively, were added. After 72 h, AP activity was assessed after ultrasound induced cell lysis (Bandelin, Berlin, Germany) in 200 µL buffer (1 % NP-40 in ALP buffer, Sigma, www.sigmaaldrich.com) and subsequent centrifugation (5 min/1000 rpm) using 4-Nitrophenylphosphate (2 mg/mL, Sigma) as substrate. Measurements were made after 15 min reaction time in a dark chamber using an ELISA reader (Tecan Genios plus, Tecan, www.tecan.com) at 405 nm. Values were calculated as turnover of pNPP (µmol /min × mg protein). Measurements were made in triplicate.
In vivo experiments
According to the results of the in vitro evaluations, implants for the in vivo experiments were sterilised under the conditions of the sterilisation protocol of set 7.
Hybridisation of BMP-ODN conjugates to nano-anchored AS on test implants
For each test implant, 100 µL of BMP-ODN solution containing 740 ng rhBMP2 conjugate to ODN strands were prepared by mixing 10 µL of 10 × PBS, 80 µL of pure water and 10 µL of conjugated growth factor solution containing 740 ng of rhBMP2. The volumes of 100 µL were pipetted onto the implants and left for hybridisation in a dark chamber at room temperature for 1 h. Care was taken to accommodate the complete volume on the implant surface and inside the perforations. Subsequently, the specimens were washed four times in PBS. 
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Two types of control implants were used: i) implants with blank SAE surfaces and ii) implants with SAE surfaces with nano-anchored ODN anchor strands (AS) but without hybridisation to oligonucleotide-growth factor conjugates. This resulted in four groups: Group 1: Implants with blank sandblasted acid-etched (SAE) surfaces. Group 2: Implants with SAE surfaces with nano-anchored AS. Group 3: Implants with SAE surface with nano-anchored AS with non-conjugated rhBMP2. Group 4: Implants with SAE surface with nano-anchored AS that were hybridised with complementary oligonucleotides conjugated to rhBMP2 as described above.
Implant placement
The implants were placed into the tibia heads of 36 female Wistar rats (average weight 449.1 g, Charles River, Sulzfeld, Germany). All surgical procedures, housing and animal care were carried out according to the regulation of the State of Lower Saxony (Reg. No. 10/0224). Implants from Groups 1 and 2 were placed into 18 animals into the right and left leg, respectively. Implants from Groups 3 and 4 were placed into one leg of another 18 animals each. For implant placement, the anterior edge of the tibial plateau was exposed through a straight skin incision and the implants were inserted self-cutting, perpendicular to the long axis of the tibia through the tibia head engaging the cortical bone with both the apex and the head of the implants. All implants achieved primary stability. After wound closure in layers, the animals were allowed to move freely and feed themselves with water and pellets ad libitum.
Histologic Processing
After 1, 4 and 13 weeks, 6 implants from each group were removed together with the surrounding bone and fixed immediately in 3 % formaldehyde. After dehydration, the bone blocks containing the implants were embedded into methylmethacrylate (Technovit Heraeus Kulzer, Hanau, Germany). Serial thick-section specimens (15-20 µm thickness, approx. distance 400 µm) were produced perpendicular to the long axis of the implants, according to Donath (1985) , and stained with alizarine / methylene blue. Specimens were serially recorded by automatic scanning (Olympus dotSlide ® , Olympus Life Science, Hamburg, Germany). All six implants were included into the evaluation of each group. Four sections through the perforations of each implant (i.e. 24 cross sections per group) were analysed, assessing three outcome parameters: Bone density of newly formed bone inside the perforations (i.e. volume of bone tissue grown into the perforations as percentage of the cross sectional area of the perforations), the percentage of implant surface covered by bone tissue and the bone density in an area of 200 µm surrounding the outer implant surface were assessed semi-automatically on the digitised images through pixel counting using image analysis software (Adobe Photoshop CS5, Adobe Systems GmbH, München) (Fig. 1B) . One calibrated blinded examiner evaluated all specimens. Average values were calculated for each implant from measurements on individual cross sections, i.e. the unit of evaluation was the individual implant. Average values for each group were then calculated from the results of the respective implants and submitted to statistical evaluation.
Due to remodelling of the tibial bone during the observation period, the portions of the implants in contact with cortical and cancellous bone, respectively, varied within the groups after 1 week and 1 month. This was addressed by separate evaluation of peri-implant bone formation around those implant parts in cortical bone and those in cancellous bone for these intervals. Wilcoxon tests (SPSS Statistics 20.0, http://support. spss.com) were used to test differences in both in vitro release and in parameters of peri-implant bone formation between the different groups and Kruskal-Wallis tests were used to test differences over time both at a level of significance of p < 0.05.
Statistics
Results
In vitro results
Hybridisation ability of AS after sterilisation
The effect of (i) different drying procedures, (ii) the addition of ethanol and (iii) the addition of different concentrations and types of sacrificial complementary strands (SCS) on the availability of AS for hybridisation with complementary ODN strands (CS) after sterilisation is shown in Fig. 2A .
The hybridisation ability of the incorporated AS decreased to 1 ± 0.4 % after sterilisation without protective measures (set 1). The effect of storage of the samples in an ethanol atmosphere during sterilisation had no measurable protective effect without an additional drying processing. Only 1.7 ± 0.6 % of the AS was able to hybridise CS after sterilisation (set 2). The combination of argonethanol-atmosphere with a drying process (phosphorus pentoxide drying (PPO)) showed an increase to 41 ± 20 % hybridisation ability (set 6).
For the introduction of SCS similar values of about 20 % to 30 % hybridisation ability were obtained for SCS1 (a) (lower concentration) and SCS2 under the conditions drying over phosphorus pentoxide and packing in wet argon-atmosphere maintains only (sets 3 and 5). Up to 80 % hybridisation availability could be obtained for SCS1 (b) applied with 32.5-35.5 pmol/cm 2 combined with drying over phosphorus pentoxide and packing in dry argon-ethanol-atmosphere (set 4). Drying over phosphorus pentoxide in combination with packing in a dry argonethanol-atmosphere without sacrificial strands (set 6) could preserve only 40 % of the hybridisation ability of the AS.
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The same conditions, combined with sacrificial strands nearly doubled the hybridisation availability to about 80 % irrespective of the concentration of SCS1 (sets 7 and 8). Table 3 shows the quality of the gamma sterilisation process for samples with SCS1 (32.5-35.5 pmol/cm 2 ) dried over phosphorous pentoxide and packed in a wet argonatmosphere. For samples infected with 25 × 10 6 CFU Pseudomonas putida, no remaining bacterial activity could . Conditions: drying (over PPO (phosphorus pentoxide)), argon-atmosphere (Ar-Atm) and ethanol additions (liquid ethanol (EtOH) or ethanol-atmosphere (EtOH-Atm)). * p < 0.05, n = 6 per set. B: in vitro release of conjugated and non-conjugated rhBMP2 from the titanium surface with nano-anchored AS (anchor strands) and SCS (sacrificial strands), (mean values, standard deviation, n = 4 pairs of samples, dual measurements per sample) (p-value = 0.029 for each pair). C: Biological activity (alkaline phosphatase) of conjugated and non-conjugated rhBMP2 (mean values, standard deviation, n = 3 samples per group, dual measurements per sample). Loading, in vitro release and bioactivity of growth factor conjugates Evaluation of loading of conjugated and non-conjugated rhBMP2 exhibited that 515.2 ng (SD 49.3) of conjugated rhBMP2 and 560.9 ng (SD 43.3) of non-conjugated rhBMP2, respectively, have been immobilised on the titanium surfaces with AS (anchor strands) and SCS (sacrificial strands). Release curves demonstrated that the delivery of non-conjugated rhBMP2 from the titanium surfaces was significantly higher than the conjugated rhBMP2 during the entire observation period of three weeks (Fig. 2B ) (p = 0.029). The assessment of biological activity exhibited comparable turnover of pNPP for both non-conjugated and conjugated rhBMP2 (Fig. 2C) .
Sterility after Sterilisation
In vivo results
All animals survived and no implant was lost. Healing was uneventful and all implants were submitted to histologic and morphometric analysis.
Histology
Early bone formation and organisation of bone debris was visible after 1 week along the implant surface and at the entrance of the perforations of implants from all groups (Figs 3 A through C). In general, implant parts located in the cortical layer exhibited more pronounced osteoconductive bone formation than those located in cancellous bone. The latter showed distinct differences in the patterns of bone formation on the surface: Implants from Group 1 and 2 exhibited formation of mineralised matrix close to but not in immediate contact with the titanium surface. Higher magnification revealed that there was a small but almost continuous non-mineralised layer between the surface and the newly formed mineralised bone matrix on implants with SAE and SAE and AS surfaces ( Figs 3A and B) . Implants with nano-anchored AS strands and hybridised conjugated rhBMP2 on the surface had a mineralised layer directly deposited on the surface in most of the areas with osteoblasts lying on top of this layer (Fig. 3D) . After 1 month, bone formation on the surface had increased and the difference between implant parts in cortical and cancellous bone had levelled off. Bone remodelling had smoothed the contours of the newly formed bone and had removed all debris. Again, there was a distinct difference in the features of bone laid down on the surfaces of the implants from the different groups. Implants from Groups 1 and 2 had small islands of bone formed on the surface that appeared to undergo remodelling and were partially separated from the implant surface by cells and organic matter (Figs. 4 A and B) . Implants from Group 4 again showed a more contiguous layer of bone in immediate contact with the implant surface (Fig. 4D) . 
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After 3 months, no differences were seen between the three groups in morphology of peri-implant bone. Implants were embedded in completely remodelled bone tissue with very few areas being located in cancellous bone.
Histomorphometry
There was a significant increase in bone implant contact (BIC) from 1 week to 13 weeks for all implant surfaces (p-values between 0.010 and 0.001) (Fig. 5A) . Comparison between the individual groups showed that implants with nano-anchored AS and hybridised conjugated rhBMP2 (Group 4) exhibited a mean bone-implant contact (BIC) rate of 21.1 % (SD 7.1) after 1 week. Implants with blank SAE surfaces (Group 1), with SAE surfaces with nano-anchored AS only (Group 2) and SAE surfaces with nano-anchored AS and non-conjugated rhBMP2 (Group 3) showed 13.9 % (SD 3.1), 16.1 % (SD 7.3), and 18.0 % (SD 4.4), respectively. Differences were significant between the groups (p = 0.045). Volume of newly formed bone inside the perforations increased significantly from 1 week to 13 weeks only for the implant with SAE surface (Group 1: p = 0.023) (Fig. 5B) . After 1 week, bone formation in the perforations had occupied 10.0 % (SD 6.7) of the area in implants with nano-anchored AS and hybridised conjugated rhBMP2 (Group 4) as compared to 4.8 (SD 2.9) in implants with SAE (Group 1), 5.7 % (SD 3.7), in implants with blank SAE surfaces and AS (Group 2) and 7.2 % (SD 7.2) in implants with SAE surface with AS and non-conjugated rhBMP2 (Group 3), respectively. Differences between group means were significant (p = 0.041). After 4 weeks, again implants with nano-anchored AS and conjugated rhBMP2 exhibited the highest BIC (54.1 % (SD 8.8)) compared with implants from Groups 3, 2 and 1 showing 46.8 (SD 8.1), 42.5 % (SD 15.5) and 45.11 % (SD .6), respectively (p = 0.029). Bone formation inside the perforations was not significantly different in the groups. After 13 weeks, no significant differences could be found between bone implant contact and bone volume in the perforations between the different groups). Peri-implant bone density ranged between 28.2-39.3 % after 1 week and increased to 30.6-40.2 % after 1 month and 39.7-40.5 % after 13 weeks (Fig. 5C) . The increase over time was not significant and no significant difference was found between the groups at the three different intervals.
Discussion
The use of a modular system for the immobilisation of biologically active molecules on biomaterials surfaces using nano-anchored oligonucleotides has been shown to be effective in previous in vitro studies ). Moreover, when bone 
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growth factors were tested, the amount of growth factors bound to the titanium surface was significantly increased and the release was significantly retarded when compared to binding of growth factors by simple adsorption (Schliephake et al., 2012a; 2012b) . As the binding is accomplished by self-assembly of oligonucleotides and ODN conjugated growth factors through hybridisation, the correct alignment of the oligonucleotides is based on the integrity of the ODN anchor strands. This may be jeopardised by sterilisation. It was thus the aim of this study was to i) develop an easy to use sterilisation process that eliminates pathogens without compromising the performance of the anchor strands (AS) for hybridisation with complementary oligonucleotide strand (CS) and ii) to test this system for its ability to enhance peri-implant bone formation in vivo. The in vitro results have shown that air-dried samples sterilised in air under normal humidity showed a complete loss of the hybridisation ability of partially incorporated AS after sterilisation. This effect is most likely accounted for by DNA strand breaks, which increase with a higher irradiation dosage (Cai et al., 2006) . Studies have shown that DNA adsorbed on a surface has been less sensitive to this effect than DNA dissolved in solution (Demanèche et al., 2001; Ciaravella et al., 2004) . However, the protective effect of adsorption to a titanium surface in the present study appeared to be too small to preserve the strand integrity. Drying of the samples for 48 h over phosphorus pentoxide and packing in protective atmosphere (argonethanol-atmosphere) has shown the strongest protective effect without addition of sacrificial strands. The positive effect of drying is most likely based on the removal of water, which is known to increase the ionisation potential of the DNA-bases (Kim et al., 1996; La Vere et al., 1996) . Additional effects would be the decrease in concentration of reactive oxygen species around the DNA by the argonatmosphere as well as the protective effect of ethanol. In addition, the OH-radical is short-lived but highly reactive and has to occur in close proximity to the DNA molecules to cause damage (Piedade et al, 2006) . Therefore a strong drying should show a protective effect (Tran et al., 2004; Grieb et al., 2002) . This goes in line with Grieb et al. (2005) , who demonstrated the effectivity of freeze-drying to reduce the formation and motility of OH-radicals as a protective measure. The protective effect of ethanol can be explained by the observation of Spotheim-Maurizot et al. (1995) who showed a positive effect of scavengers in preserving DNA integrity by catching the reactive oxygen species before they can react with DNA.
The protective effect of environmental conditions has been even more enhanced by the use of sacrificial strand sequences (SCS). The potential of the SCS to protect the incorporated AS against degradation during the sterilisation process has varied considerably depending on the SCS type and surface concentration as well as the environmental atmosphere. The positive effect of SCS on the AS ability for hybridisation after sterilisation may be based on the same principle as the protective effect of proteins for DNA by causing a dense packing of the DNA and induce a higher radiation resistance by precluding the hydrogen atom on 5 position of the base which is especially sensitive to attacks by OH-radicals (Begusova et al., 2000; Valota et al., 2003) . This protective effect has even been considerably increased by increasing the concentration of SCS1. However, when the SCS1-addition was raised to 32.5-35.5 pmol/cm 2 , the strands competed with the incorporated AS during hybridisation, which necessitated a removal step before hybridisation. The enhanced protection of the high concentration of SCS1 in combination with a wet Argon atmosphere has been also achieved with the lower SCS1 concentration when used in combination with a dry argon-atmosphere. For this reason, set no. 7 has been selected for sterilisation of the implants used in the in vivo experiments.
The SCS2 strands applied with a surface concentration of 56 pmol/cm 2 did not provide a convincing degree of protection, despite their high density. A reason for this unexpected effect may be that SCS1 and SCS2 differ in their length and, hence, may differ in conformation under the experimental conditions used. Goddard et al. (2000) showed that short single strand areas (8-30 bases) have a sequence-dependent conformational dynamics (Goddard et al., 2000) . The end-to-end length is decreasing in a single DNA-strand after the length exceeds 40 bases as the polymer properties dominate the conformation (Walker et al., 1998; Castelino et al., 2005) . Therefore, the SCS1 should have a higher flexibility and could form a denser layer on the surface -in contrast to the SCS2, which had less possible conformations. This could have reduced the electron capture and thus the protecting effect of the SCS (Leforestier et al., 1993; Ray et al,. 2005) . In summary, the use of small amounts of sacrificial ODN strands in combination with a dry argon-atmosphere has been able to protect the hybridisation ability of ODN anchor strands, during effective sterilisation of the implants with 25 kGy gamma irradiation.
The aim of the in vivo part of the present study, was to test the ability of this system of controlled binding and release of rhBMP2 for its ability to enhance periimplant bone formation under in vivo conditions. When implants are coated with bone growth factors, peri-implant bone formation can be enhanced through induction of bone formation in the regenerating tissue surrounding the implant surface, on the one hand. This would be predominantly mediated by the portion of growth factor released from the implant surface and result in increased peri-implant bone density. On the other hand, bone cells are recruited to the implant surface by gradients of released growth factors which would enhance the bone implant contact. Evaluation of peri-implant bone density at a distance of 200 µm from the surface has shown that there was a parallel increase in all four groups over time but no differences between the groups at any of the intervals. This suggests that the character of the surface as well as the mode of BMP loading and release did not significantly enhance the volume of bone formation in the vicinity of the implant. This appears to be contradictory to the fact that BIC has been significantly increased after 1 week and 1 month. The histologic features, however, indicate that the newly formed bone layers in contact with the implant surface have been very thin and did not significantly add to the peri-implant bone volume. The findings suggest that www.ecmjournal.org H Schliephake et al.
Immobilisation of bone morphogenic protein 2 on titanium implants the amount of both non-conjugated and conjugated BMP2 released from the surfaces was too small to induce bone formation in the vicinity of the implants. However, the amount of BMP2 remaining on the surface in the group of implants with conjugated rhBMP2 may have recruited undifferentiated cells to the implant surface, through a slower and continuous release and increased osteogenic differentiation through the larger amount of BMP2 retained on the surface. This would have resulted in formation of a thin bone layer in immediate contact with the implant surface. This would be in line with the observation from previous in vitro studies that rhBMP2 is maintained longer on the implant surface and enhances both proliferation and early osteogenic differentiation of human mesenchymal stem cells grown on the surface (Schliephake et al., 2012a) . The morphometric data of the present study, indicate that it is merely early bone formation that is enhanced because there was no difference in any of the assessed parameters after 13 weeks of implantation. The features seen in implants with SAE and SAE & AS surface indicate that bone formation at the implant surface follows a different pattern without BMP bound to the surface. In general, it is obvious that differences between results in the different groups at each interval appeared to be small. Part of this effect may be explained by the fact that bone conditions for this experiment were uncompromised. The morphologic and morphometric data indicate that the biological effect of the nano-anchored BMP signals appears to be mainly confined to the cell layers on the implant surface, with a small range of action. As the concentration gradient is important for the function of BMPs in tissue development, the distance from the implant surface up to which the growth factors are effective will be a matter of dosage deposited on the surface. A previous in vitro evaluation had shown that approximately 335 ng/cm² rhBMP2 can be nano-anchored to the surface (Schliephake et al., 2012a) . A previous in vivo study had shown that a constant release of > 100 ng / 72 h is required to induce ectopic bone formation (Gruber et al., 2009) . Moreover, burst release from soak loaded collagen carriers between 1 µg and 10 µg of BMP would be necessary for successful ectopic bone induction (Arosarena et al., 2005; Winn et al., 1999) . A recent study using polyelectrolyte multilayer films to accommodate BMP2 on the surface of titanium implants had shown that a release between 4 and 14 µg successfully induced ectopic bone formation in rodents (Guillot et al., 2013) . The dosages released from the present implants into peri-implant tissue fall short of these amounts and thus suggest that the released amount of rhBMP2 from the titanium surfaces equipped with ODN anchor strands is too small to independently induce sustainable bone formation in the peri-implant regenerating tissue, as the level of native osteogenic signalling in this rodent model of non-compromised bone biology is high enough to maintain osteogenesis on its own.
In this way the results correspond to those of previous studies in which small amounts of BMP2 were anchored to and released from titanium implants without being able to increase peri-implant bone density compared to implants coated with the carrier alone (Schliephake et al., 2005 Stadlinger et al., 2008; Ramazanoglu et al., 2011) .
In contrast to these reports, however, the present study suggests that rhBMP2 hybridised to nano-anchored ODN strands on titanium surfaces appears to be effective because of the portion of growth factor attached to the surface by cells recruited to the surface and enhancing bone implant contact.
Conclusions
Binding of growth factors to titanium surfaces through nano-anchored ODN strands may be jeopardised by sterilisation using gamma irradiation. The present study has shown that deprivation of water as well as the sterilisation in a dry argon-ethanol-atmosphere, in combination with the application of the sacrificial ODN strands, allowed for maintenance of up to 80 % of the hybridisation ability of nano-anchored ODN strands. Using this process for sterilisation of titanium implants has maintained the functionality of this modular system for binding of rhBMP2 to the implant surface. rhBMP2 hybridised to nano-anchored ODN strands on the implant surface has been effective in vivo through the portion of growth factor attached to the surface by enhancing bone implant contact.
